Getting Started on ELAPRASE

IMPORTANT SAFETY INFORMATION

RISK OF SERIOUS ALLERGIC REACTIONS

Some patients have experienced serious allergic reactions (including life-threatening anaphylactic reactions) during and up to 24 hours after treatment, regardless of how long they were taking ELAPRASE. Anaphylactic reactions are immediate and include breathing problems, low oxygen levels, low blood pressure, hives and/or swelling of the throat or tongue. If a patient (you or your child) has experienced an anaphylactic reaction, the patient may require an extended period of observation by the patient’s healthcare team. If you or your child has breathing problems, a fever, or a respiratory illness, you or your child may be at risk of life threatening worsening of those conditions due to allergic reactions from ELAPRASE. Your healthcare team should be advised of those conditions before treatment with ELAPRASE because the information may affect the timing of ELAPRASE treatment.

Please see full Prescribing Information and additional Important Safety Information below.

Getting Started on ELAPRASE (idursulfase)

If you and your doctor decide that ELAPRASE is right for you or your child, OnePath® can help you access therapy. Shire and OnePath are committed to providing product support services to patients and their families affected by Hunter syndrome.

Eligible patients who sign up with OnePath will be assigned a Patient Support Manager who will help address questions you may have about access to your therapy.

Support for eligible Hunter syndrome patients and their families with OnePath.

Coordinated care
We can help with details of your ELAPRASE therapy, including providing you with information to locate a treatment center, if necessary, and arranging delivery of ELAPRASE to the treatment center.

Helping to get you started
First you should discuss ELAPRASE therapy with your doctor; you and your doctor may then decide to sign a OnePath Start Form (English | Español). You don’t have to sign the Start Form to receive ELAPRASE therapy, but you will need to do so if you would like to receive OnePath product support services. After you and your doctor sign the form, your doctor will fax it to us and we’ll handle the rest.

> Learn about reimbursement > Meet the OnePath Support Team

What is ELAPRASE^® (Idursulfase)?

ELAPRASE is a prescription medicine for patients with Hunter syndrome.

ELAPRASE has been shown to improve walking ability in patients 5 yrs and older.

In patients 16 months to 5 yrs old, ELAPRASE did not show improvement in disease-related symptoms or long term clinical result; however, treatment with ELAPRASE has reduced spleen size similarly to patients 5 yrs and older.

It is not known if ELAPRASE is safe and effective in children under 16 months old.

RISK OF SERIOUS ALLERGIC REACTIONS

Risk of serious allergic reactions:
Some patients have experienced serious allergic reactions (including life-threatening anaphylactic reactions) during and up to 24 hours after treatment, regardless of how long they were taking ELAPRASE. Anaphylactic reactions are immediate and include breathing problems, low oxygen levels, low blood pressure, hives and/or swelling of the throat or tongue.

If a patient (you or your child) has experienced an anaphylactic reaction, the patient may require an extended period of observation by the patient’s healthcare team.

If you or your child has breathing problems, a fever, or a respiratory illness, you or your child may be at risk of life-threatening worsening of those conditions due to allergic reactions from ELAPRASE. Your healthcare team should be advised of those conditions before treatment with ELAPRASE because the information may affect the timing of ELAPRASE treatment.

You or your child should be closely watched during and after ELAPRASE treatment and you should confirm with your healthcare team in advance of treatment that it is prepared to manage serious allergic reactions, including anaphylactic reactions. Tell your healthcare team immediately if any signs of an allergic reaction happen. Those signs may include breathing problems, low blood pressure, rash, hives, itching, flushing, fever and/or headache.

When serious allergic reactions happened during clinical trials, later ELAPRASE treatments were managed with allergy-controlling drugs before or during treatment, a slower rate of ELAPRASE treatment, and/or early discontinuation of treatment.

Children with serious genetic mutations may be at risk for allergic reactions, serious side effects and antibody development. In a clinical study of children 7 years and younger, patients with certain types of genetic mutations experienced a higher number of allergic reactions, serious side effects, and development of an immune response to treatment. This immune response may interfere with the effectiveness of ELAPRASE. Talk to your healthcare team about whether you or your child may be at risk.

If you or your child has breathing problems, other respiratory illness, heart problems, or susceptibility to fluid overload, you or your child may be at higher risk of fluid overload during ELAPRASE treatment. Your healthcare team should be advised of those problems before treatment and you should confirm with your healthcare team in advance of treatment that it is appropriately trained to watch for signs of fluid overload and provide the necessary medical support. Patients at risk for fluid overload may require longer observation time.

What are possible side effects of ELAPRASE?
The most common side effects of ELAPRASE include:

In patients aged 5 and older:
- Headache
- Itching
- Muscle and bone pain
- Hives
- Diarrhea
- Cough
In patients aged 7 years or younger:
- Fever
- Rash
- Vomiting
- Hives

The most common side effects needing medical attention were allergic reactions, and included rash, hives, itching, flushing, fever, and headache. Tell your healthcare team immediately if any signs of an allergic reaction happen. These are not all the possible side effects of ELAPRASE.

For additional safety information, please click here for Full Prescribing Information, including Boxed Warning for Risk of Anaphylaxis, and discuss with your doctor

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

S44474 02/19